Skip to main content

Advertisement

Fig. 1 | Cell & Bioscience

Fig. 1

From: IGFBP7 inhibits cell proliferation by suppressing AKT activity and cell cycle progression in thyroid carcinoma

Fig. 1

IGFBP7 is downregulated in human thyroid cancer samples. a Representative images of IGFBP7 immunostaining in normal thyroid tissue, thyroid adenoma and thyroid carcinoma specimens with different pathological characteristics. b Statistical analysis of the proportions of negative or positive IGFBP7 expression in clinical specimens of thyroid adenoma and thyroid carcinoma with different pathological subtypes. c Representative images of IGFBP7 immunostaining in two different papillary thyroid cancer (CPTC/FPTC) tissues

Back to article page